Page 84 - SAMRC Annual Report 2023-24
P. 84

Intersection of
                                                               Non-communicable Diseases
                                                               and Infectious Diseases

                                                               Research Unit





                                                               Unit director:
                                                               Prof. Ntobeko Ntusi





            Prioritising responsive research                   Equitable capacity development
            through impactful interventions                    for empowering communities

            Over the 2023/24 reporting period, the work of the   We have numerous students who are undertaking
            Intersection of Non-communicable and Infectious    research projects embedded in the studies
            Disease Research Unit has focused on 7 key         described above for masters, doctoral, postdoctoral
            programmes:                                        and early career research programmes. In addition
                                                               to the formal capacity building through academic
            (1)  Understanding the biology of heart failure among   training, the students regularly attend conferences
               Africans, the contribution of associated infections   and workshops, where they present their data
               to outcomes, and the association of anaemia with   and results, and have also had opportunities for
               outcome of heart failure, as well as studies on the   exchange with collaborators.
               genomic basis of cardiomyopathy in Africans;

            (2)  Studies  on  the biology  of  HIV-associated   Science for creating a
               cardiovascular disease in adults and adolescents   healthier society
               with a focus on both mechanistic studies as well
               as outcome studies, including clinical trials;   In the past year, we have had two opportunities to
                                                               present our research to patient groups, both at the
            (3)  Studies on the biology of tuberculosis and the   University of Cape Town as well as in the Kensington
               cardiovascular system, using imaging biomarkers   clinic.  In  addition,  our  research has  been  featured
               and well as focus on outcomes;                  in two issues of Nature Africa. As the Principal
                                                               Investigator (PI) of the group, I have been invited on
            (4)  Ongoing studies of the biology of COVID-19 as   different radio stations to speak about some of the
               well as cardiovascular and all-cause outcomes   research we do and some of our findings.
               and mortality in individuals with COVID-19;

            (5)  Studies on the role of cardiovascular magnetic   In celebration of 30 years of
               resonance in rheumatic heart disease, as well as   democracy in South Africa
               studies of peotoemic and metanolomic profiling
               in individuals with rheumatic heart disease;    We believe that health research is an important
                                                               mechanism not only to  improve the health of the
            (6)  Studies  of the  role of  H.  pylori in  the   nation, but also to improve the economy of the
               pathophysiology and in influencing outcomes in   nation. Our commitment is to continue to contribute
               patients with resistant hypertension;           to quality health research and through knowledge
                                                               generation in hope to contribute to a healthier
            (7)  Studies of predictors of outcome in individuals   South Africa.
               with preeclampsia and other forms of pregnancy-
               induced hypertension in individuals with and    We are immensely grateful to the SAMRC for the
               without HIV infection.                          continued support of our work.




            82          SAMRC  ANNUAL REPOR T 2023-24
   79   80   81   82   83   84   85   86   87   88   89